Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
SUNLINK HEALTH SYSTEMS Aktie jetzt für 0€ handeln | |||||
Mo | Regional Health Properties und SunLink Health Systems verlängern Frist für Fusionsvereinbarung | 1 | Investing.com Deutsch | ||
Mo | SUNLINK HEALTH SYSTEMS INC - 8-K, Current Report | 3 | SEC Filings | ||
13.05. | SunLink Health Systems GAAP EPS of -$0.09, revenue of $7.32M | 1 | Seeking Alpha | ||
13.05. | SUNLINK HEALTH SYSTEMS INC - 10-Q, Quarterly Report | 1 | SEC Filings | ||
15.04. | SUNLINK HEALTH SYSTEMS INC - 8-K, Current Report | 1 | SEC Filings | ||
15.04. | Regional Health Properties, Inc.: Regional Health Properties And Sunlink Health Systems Revise All-stock Merger Transaction | 148 | GlobeNewswire (Europe) | Atlanta, GA, April 15, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. ("Regional") (OTCQB: RHEP) (OTCQB: RHEPA) and SunLink Health Systems, Inc. ("SunLink") (NYSE American: SSY) jointly... ► Artikel lesen | |
12.02. | SunLink Health Systems GAAP EPS of -$0.19, revenue of $7.93M | 1 | Seeking Alpha | ||
12.02. | SunLink Health Systems, Inc. Announces Fiscal 2025 Second Quarter Results | 100 | Business Wire | ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $1,070,000 (or a loss of $0.15 per fully diluted share) for its... ► Artikel lesen | |
12.02. | SUNLINK HEALTH SYSTEMS INC - 10-Q, Quarterly Report | - | SEC Filings | ||
06.01. | SUNLINK HEALTH SYSTEMS INC - 8-K, Current Report | 1 | SEC Filings | ||
06.01. | SunLink Health Joins Forces With Regional Health Properties In All-Stock Deal: Shares Surge | 1 | Benzinga.com | ||
06.01. | Regional Health Properties to acquire SunLink Health in an all-stock deal | 5 | Seeking Alpha | ||
06.01. | Regional Health Properties, Inc.: Regional Health Properties And Sunlink Health Systems To Merge In An All-stock Transaction | 179 | GlobeNewswire (Europe) | Enhances Opportunity to Increase Shareholder Value Significantly Strengthens Balance Sheet Expands Regional Board with the Addition of Two Highly Qualified Industry Veterans Atlanta, GA, Jan. 06,... ► Artikel lesen | |
12.11.24 | SunLink Health Systems, Inc. Announces Fiscal 2025 First Quarter Results | 114 | Business Wire | ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $442,000 (or a loss of $0.06 per fully diluted share) for its first... ► Artikel lesen | |
01.10.24 | SunLink Health Systems, Inc. Announces Fiscal 2024 Fourth Quarter and Annual Results | 142 | Business Wire | ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $652,000 (or a loss of $0.09 per fully diluted share) for its fourth... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SERNOVA BIOTHERAPEUTICS | 0,109 | +3,81 % | Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair | LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,745 | -2,49 % | Atossa Genetics Year-end 2024 slides: (Z)-endoxifen shows promise, expenses decline | ||
PING AN HEALTHCARE | 0,946 | +1,42 % | PA GOODDOCTOR (01833): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 JUNE 2025 | ||
MOUNTAIN VALLEY MD | 0,014 | -5,41 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
CO-DIAGNOSTICS | 0,242 | +2,54 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
CYTOSORBENTS | 1,028 | -0,19 % | Cytosorbents Corp: CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb-ATR | PRINCETON, N.J., June 24, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
VERU | 0,565 | +9,51 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment... ► Artikel lesen | |
VOLITIONRX | 0,750 | -11,00 % | VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Friday, May 16 at 8:30 a.m. U.S. Eastern Time
HENDERSON, Nev., May 15, 2025 /PRNewswire/... ► Artikel lesen | |
EKSO BIONICS | 3,400 | -4,76 % | XFRA 23E0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILEKSO BIONICS. NEW... ► Artikel lesen | |
IMUNON | 0,665 | +4,72 % | Imunon, Inc.: IMUNON Presents Positive Phase 2 Translational Data of IMNN-001 in Advanced Ovarian Cancer at ESMO Gynaecological Cancers Congress 2025 | ASCO 2025 overall survival data bolster IMNN-001's potential in advanced ovarian cancer, supported by robust translational results at ESMO Results from OVATION 2 Study reinforce IMNN-001 mechanism... ► Artikel lesen | |
BEYOND AIR | 0,146 | +3,55 % | Beyond Air-Aktionäre genehmigen Reverse-Aktiensplit | ||
AVINGER | 0,340 | -6,08 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
NOVACYT | 0,492 | -0,20 % | Novacyt S.A. - Result of AGM | ||
AROVELLA THERAPEUTICS | 0,071 | +22,61 % | AROVELLA THERAPEUTICS LIMITED: Application for quotation of securities - ALA |